| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 326.629 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 315.122 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 371.235 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 318.907 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 367.499 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 412.982 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 648.859 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 207.198 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1055.54 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 689.742 | 94 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 227.115 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1131.8 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 252.482 | 86 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 540.918 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 352.547 | 89 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 253.927 | 86 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 602.463 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 331.504 | 88 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 229.675 | 85 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 226.118 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 361.275 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 212.064 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 286.044 | 87 |